SEC Form 4 · accession 0001209191-15-010091
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan T Sullivan
Officer — Sr. VP and General Counsel
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 8:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 3, 2015 | A | 5,865 | $0.00 | A | 30,865 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $37.81 | Feb 3, 2015 | A | 24,360 | A | — | Feb 3, 2025 | Common Stock | 24,360 | 24,360 | D |
| Performance Restricted Stock UnitsF3 | — | Feb 3, 2015 | A | 6,350 | A | — | — | Common Stock | 6,350 | 6,350 | D |
Explanation of responses
- F1Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2015.
- F2The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date is January 1, 2015.
- F3Represents performance restricted stock units granted to the Reporting Person. Each performance restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock. In the event that the volume-weighted average price of the Issuer's common stock equals or exceeds (i) $80.00 per share for 30 consecutive trading days prior to the first anniversary of the Vesting Commencement Date or (ii) $100.00 per share for 30 consecutive trading days prior to the second anniversary of the Vesting Commencement Date, the shares subject to the award shall vest in two equal annual installments following the date on which the condition specified in clause (i) or (ii) is met. The Vesting Commencement Date is January 1, 2015.